Oncology Overdrive podcast

#Fitness #Medicine #Healio #Shikha Jain #Cancer #Healthcare #Oncology #Socialmedia #Science #Biology

26:18

How do you know when it’s time to make your next big career move? With International Women’s Day around the corner, we are excited to feature Avni Patel Thompson, Founder and CEO of Milo. Avni is building technology that directly supports the often overlooked emotional and logistical labor that falls on parents—especially women. Milo is an AI assistant designed to help families manage that invisible load more efficiently. In this episode, Avni shares her journey from studying chemistry to holding leadership roles at global brands like Adidas and Starbucks, to launching her own ventures. She discusses how she approaches career transitions, the importance of unpleasant experiences, and why she’s focused on making everyday life easier for parents. [01:26] Avni's University Days and Early Career [04:36] Non-Linear Career Paths [05:16] Pursuing Steep Learning Curves [11:51] Entrepreneurship and Safety Nets [15:22] Lived Experiences and Milo [19:55] Avni’s In Her Ellement Moment [20:03] Reflections Links: Avni Patel Thompson on LinkedIn Suchi Srinivasan on LinkedIn Kamila Rakhimova on LinkedIn Ipsos report on the future of parenting About In Her Ellement: In Her Ellement highlights the women and allies leading the charge in digital, business, and technology innovation. Through engaging conversations, the podcast explores their journeys—celebrating successes and acknowledging the balance between work and family. Most importantly, it asks: when was the moment you realized you hadn’t just arrived—you were truly in your element? About The Hosts: Suchi Srinivasan is an expert in AI and digital transformation. Originally from India, her career includes roles at trailblazing organizations like Bell Labs and Microsoft. In 2011, she co-founded the Cleanweb Hackathon, a global initiative driving IT-powered climate solutions with over 10,000 members across 25+ countries. She also advises Women in Cloud, aiming to create $1B in economic opportunities for women entrepreneurs by 2030. Kamila Rakhimova is a fintech leader whose journey took her from Tajikistan to the U.S., where she built a career on her own terms. Leveraging her English proficiency and international relations expertise, she discovered the power of microfinance and moved to the U.S., eventually leading Amazon's Alexa Fund to support underrepresented founders. Subscribe to In Her Ellement on your podcast app of choice to hear meaningful conversations with women in digital, business, and technology.…

Oncology Overdrive

Series home•Feed

In this podcast by Healio, host Shikha Jain, MD, FACP, covers modern day health care in an ever-evolving world. Through interviews with experts, Jain explores hot topics in oncology and beyond.

100 episodes

Oncology Overdrive

updated 29 days ago

Series home•Feed

In this podcast by Healio, host Shikha Jain, MD, FACP, covers modern day health care in an ever-evolving world. Through interviews with experts, Jain explores hot topics in oncology and beyond.

100 episodes

#Fitness #Medicine #Healio #Shikha Jain #Cancer #Healthcare #Oncology #Socialmedia #Science #Biology

Wszystkie odcinki

Oncology Overdrive

1
Pioneering Changes in Patient Advocacy with Kimberly Richardson 33:58

29 days ago33:58

33:58

In this episode, host Shikha Jain, MD, speaks with Kimberly Richardson about driving changes in patient advocacy efforts, the importance of including DEI in cancer research and clinical trials and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Richardson 0:20 • The interview 1:15 • How did you get to where you are today as such a leader and advocate? 1:56 • Did you feel welcomed into this space when you started doing your advocacy work, or did you feel like it was an uphill battle? 5:12 • Jain and Richardson on how physicians and patient advocates can come up with solutions that coincide with the transformation of what advocacy work has become. 8:23 • What are the different ways people can be patient advocates? 10:59 • Jain and Richardson on research advocacy and the power of the ripple effect when it comes to how this work impacts patients. 15:45 • Jain and Richardson on how physician and patients can collaborate to overcome institutional challenges with timing of visits and quality of care. 19:11 • Richardson and Jain on educating patients in underrepresented communities on research and policy changes that will lead to more diversity in clinical trials. 24:21 • If you could look back one year from now, what do you hope your research grant accomplishes? 30:00 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 32:00 • How to contact Richardson 32:33 • Thanks for listening 33:27 Kimberly Richardson is a survivor of ovarian cancer and early stage, triple positive breast cancer. Kimberly has founded the Black Cancer Collaborative , a 501 (c)3 nonprofit organization that creates partnerships between Black cancer patients and the medical and scientific communities on issues of health equity, patient inclusion and clinical trials participation. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Richardson can be found on Bluesky under Black Cancer Collaborative and on LinkedIn . Disclosures: Jain and Richardson report no relevant financial disclosures.…

Oncology Overdrive

1
Survivorship and Visual Storytelling with Anna Rathkopf 35:41

6 weeks ago35:41

35:41

In this episode, host Shikha Jain, MD, speaks with Anna Rathkopf about the mental and physical toll of cancer treatment and survivorship, using photography to connect with patients and caregivers and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Rathkopf 0:20 • The interview 1:23 • How did you get into storytelling through photography around your cancer diagnosis and your caregiver experience? 1:46 • How did you navigate questions and challenges surrounding fertility during the first five years of your diagnosis? 4:07 • On top of everything else going on in your life at the time, how did your decision to document your treatment become part of your plan? Why was it so important for you to do in that moment? 7:50 • Did photography help you feel like you had some control in your life? 10:45 • Overall, how did this impact your mental health along with your physical health? 11:17 • What were you doing from a photojournalistic standpoint prior to your diagnosis? How did that prepare you for this next step in what you have created? 14:46 • How did your partner’s caregiving responsibilities incorporate into your photography? 16:48 • Jain and Rathkopf on the sacrifices caregivers make. 19:53 • If you had to give advice to someone going through the initial time after cancer diagnosis, caregiver or patient, what would you say you would do the same or differently? 21:29 • What do you suggest loved ones do or say to help patients and caregivers? 24:49 • What was the transition into survivorship like for you after the first five years? How did that change your mentality? 27:24 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 33:34 • How to contact Rathkopf 34:20 • Thanks for listening 35:22 Anna Rathkopf is an award-winning photographer whose work focuses on empathy, health, and identity. She is the author of HER2: The Diagnosed, The Caregiver, and Their Son , a poignant exploration of the realities of cancer under 50. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Rathkopf can be found on Instagram @rathkopfphotography . Purchase HER2: The Diagnosed, The Caregiver, and Their Son on Amazon or on the website www.rathkopf.com . For more from the Rathkopfs: Check out photos and video from their installation at A(I) Brighter Tomorrow: Cancer and Beyond) exhibition at Montefiore Einstein through April 18, 2025. Disclosures: Jain and Rathkopf report no relevant financial disclosures.…

Oncology Overdrive

1
Diversity and Development in Hematology with Belinda Avalos, MD 31:04

8 weeks ago31:04

31:04

In this episode, host Shikha Jain, MD, speaks with ASH president, Belinda Avalos, MD, about the importance of DEI practices in medicine, leading molecular medicine developments and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Avalos 0:18 • The interview 1:18 • How did you know you know you wanted to be a hematologist and how did you end up in this space doing the work you’re doing now? 1:47 • Jain and Avalos on the innovations and patient relationships in the field of HemOnc that drive physician interest. 3:25 • What drove your passion to get involved in DEI and equitable care in medicine? 5:08 • Jain and Avalos on diversity in clinical trials. 7:48 • Jain and Avalos on the importance of multidisciplinary approaches to patient care. 9:08 • What do you see as the biggest barriers to driving change in this space? How can we actually make changes that will result in real-world transformation? 10:11 • Tell me about the work that you do in the spaces of women in hematology and medicine. 11:25 • What types of things should we be doing to drive gender equity changes in medicine? 13:40 • Do you feel hopeful about where we are going with the changes being driven by societies like ASH? 15:24 • What else excites you about hematology and the innovation in the field now? 17:02 • What are the biggest transformations we are going to see in hematology over the next decade? 23:26 • Where will you be focusing your time moving forward? 27:53 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 29:16 • How to contact Avalos 30:15 • Thanks for listening 30:44 Belinda R. Avalos, MD, is the American Society of Hematology 2025 president, and is a professor of medicine and a senior advisor to the president of Atrium Health Levine Cancer. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Avalos can be reached by contacting ASH at www.hematology.org . Disclosures: Jain and Avalos report no relevant financial disclosures.…

Oncology Overdrive

1
The Role of Machine Learning in Clinical Trials with Damon Rasheed 21:11

12 weeks ago21:11

21:11

In this episode, host Shikha Jain, MD, speaks with Opyl co-founder Damon Rasheed about using machine learning to better predict clinical trial outcomes, handling ethical concerns surrounding AI in health care and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Rasheed 0:20 • The interview 0:58 • How did you end up in the AI-powered medicine and clinical trials? 1:48 • What is Opyl, and what is TrialKey? 3:54 • Is TrialKey predominantly based in Australia or is it available outside of Australia as well? 5:34 • Can you explain how machine learning works in order to create these outcomes? 6:11 • How do you see people utilizing this tool in the future based on what you have already seen? 8:30 • How have others received this? What is the feedback you have gotten surrounding what people are excited and concerned about with this technology? 10:50 • Does this type of product take into account the issue of diversity in clinical trials? 13:41 • What’s next for expanding Opyl and TrialKey? 14:27 • What keeps you excited and motivated to continue working in this space? 15:28 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 19:35 • How to contact Rasheed 20:16 • Thanks for listening 20:54 Damon Rasheed is a serial entrepreneur recognized for his groundbreaking ventures and deep expertise in machine learning and big data. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Rasheed can be reached at opyl.ai or trialkey.ai . Disclosures: Jain reports no relevant financial disclosures. Rasheed reports TrialKey is powered by Opyl Limited, which is a publicly listed company operating on the ASX.…

Oncology Overdrive

1
Highlights from ASH 2024 (Meeting Mic Re-Release) 24:11

13 weeks ago24:11

24:11

In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the ASH Annual Meeting and Exhibition, as well as Healio’s top headlines from the meeting. Gwen L. Nichols, MD, reviews a panel discussion on how hematologists and oncologists can best address patients’ concerns as AI’s role in medicine invariably expands. :24 Thomas G. Knight, MD, addresses financial toxicity for people with blood cancer. 6:29 Charles S. Abrams, MD, discusses results of the HIBISCUS trial and its implications for vaso-occlusive events. 16:30 Read the full coverage here: AI in hematology: ‘The good, the bad and the ugly’ Mitigating financial toxicity ’better than any drug’ for people with cancer Etavopivat could offer ‘great benefit’ in sickle cell disease ASH recognizes Judith Kleinerman, MD, with Exemplary Service Award GLP-1s reduce thrombosis risk among people with diabetes, regardless of obesity We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Disclosures: Jain reports no financial disclosures. Abrams reports he is chair of the ASH Research Collaborative's Sickle Cell Disease Clinical Trials Network Oversight Committee. Knight reports no relevant financial disclosures. Nichols reports no relevant financial disclosures.…

Oncology Overdrive

1
“Back to the Future”: Developments in Immunotherapy with David Gandara, MD 39:30

14 weeks ago39:30

39:30

In this episode, host Shikha Jain, MD, speaks with David Gandara, MD, about how ctDNA and CAR-T cell therapies are transforming precision medicine, the importance of patient reported outcomes and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Gandara 0:19 • The interview 1:02 • Can you tell me a little more about what you are working on now? 1:25 • How did you get engaged with the community in Hawaii? 6:30 • What do you think is going to happen with ctDNA moving forward? 8:29 • Can you utilize ctDNA and minimal residual disease information to determine how long patients need to be on adjuvant therapy? 11:42 • How did you get into the ctDNA space? 15:06 • How do you see AI transforming health care beyond providing patients with more information and taking more ownership of their health? 18:28 • Can you tell us more about how a second opinion clinic works? How did this type of clinic develop and become part of what you do? 23:17 • What are some of your predictions as to what will happen in oncology care over the next ten to twenty years? 29:00 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 37:30 • How to contact Gandara 38:47 • Thanks for listening 39:10 David Gandara, MD, is a clinician-scientist and lung cancer specialist internationally recognized for his expertise in thoracic cancers, cancer drug development and biomarker development. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Dr. Gandara can be reached via email drgandara@ucdavis.edu . Disclosures: Jain reports no relevant financial disclosures. Gandara reports institutional research grants from Astex, Amgen and Genentech; institutional consulting for AstraZenica, Exact Sciences, Genentech, Guardant Health, IO Biotech and Oncohost; consulting for Adagene, Henlius USA, Foundation Medicine and Sanofi; serves on the advisory board of Abbvie, Janssen, Merck, Mirati, Regeneron and Revolution Medicine.…

Oncology Overdrive

1
Enhancing Clinical Trial Enrollment with Michel van Harten, MD 25:27

16 weeks ago25:27

25:27

In this episode, host Shikha Jain, MD, speaks with Michel van Harten, MD, about creating better information systems for physicians and patients, how shared decision-making can improve drug development and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About van Harten 0:20 • The interview 1:00 • What was your journey to becoming a physician and beyond to where you are now? 1:24 • How did you learn the necessary skills to be an exceptional leader in this space? 2:51 • How many years were you a practicing physician for? 3:53 • What does myTomorrows do, and what drew you to this type of work? 4:54 • Where is this service available? 7:19 • Jain and van Harten on the challenges patients face surrounding eligibility for clinical trials. 8:36 • Where do you see this going down the line? 10:05 • Has your company looked into how to these services can impact diversifying clinical trial enrollment? 12:04 • What are some challenges your company has faced? 13:50 • How quickly do you think growth will accelerate in this space? 15:26 • How will this work and resource have major impacts on drug development in a more accelerated way than in the past? 16:11 • From the patient-facing side, have you faced any challenges concerning patients’ willingness to be enrolled in clinical trials? 18:22 • What is next for you, and where do you see yourself in twenty years? 19:13 • Do you have any concerns about AI in health care? […] What should we be aware of when utilizing AI in this space? 19:45 • Jain and van Harten on the challenges and setbacks that come from outdated and inaccurate clinical trial databases. 21:35 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 23:50 • How to contact van Harten 24:28 • Thanks for listening 25:17 Michel van Harten, MD, is the CEO of myTomorrows. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Michel van Harten can be reached via email michel.vanharten@mytomorrows.com . Disclosures: Jain and van Harten report no relevant financial disclosures.…

Oncology Overdrive

1
The Data Behind Precision Medicine with Melody Harris 25:35

17 weeks ago25:35

25:35

In this episode, host Shikha Jain, MD, speaks with Melody Harris about the evolution of precision medicine, what physicians and companies can do to help patients better understand precision oncology and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Harris 0:20 • The interview 1:11 • Tell us about how you ended up in this niche role. 1:32 • How did you make the decision to move from practicing law to transitioning your career into this space? 3:56 • Jain and Harris on the “hype” around precision medicine. 7:11 • What is the central thesis of the work at NeoGenomics? 10:36 • What do you feel companies need to be doing to make expectations surrounding diagnoses more transparent for patients? 11:49 • Where do you think this is all going in the future? Where do you think we’ll be in another ten or twenty years? 13:30 • What do you see yourself doing next? 19:04 • How can companies address the disparities in health care access, especially in underserved areas? 21:06 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 23:32 • How to contact Harris 24:30 • Thanks for listening 25:14 Melody Harris serves as chief operations officer and president of informatics at NeoGenomics, a leading oncology testing services company. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Harris can be reached at melody.harris@neogenomics.com . Disclosures: Jain and Harris report no relevant financial disclosures.…

Oncology Overdrive

1
Highlights from 2024 World Conference on Lung Cancer (Meeting Mic Re-Release) 19:18

18 weeks ago19:18

19:18

In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting. With insights from Benjamin P. Levy, MD, and top headlines from the conference, Meeting Mic is your on-the-go source for highlights, pearls, and perspectives across all specialties. Benjamin P. Levy, MD, discusses key takeaways from the meeting. 0:49 Read the full coverage here: Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’ Source: Zhou C, et al. Abstract 2700. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. Perioperative nivolumab improves outcomes in resectable NSCLC Source: Forde PM, et al. Abstract 3589. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. Despite progress, barriers to lung cancer biomarker testing persist Source: Smeltzer M, et al. Abstract 3000. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Levy at the time of posting.…

Oncology Overdrive

1
Health Care Advocacy During Elections with Alice Chen, MD 47:14

20 weeks ago47:14

47:14

In this episode, host Shikha Jain, MD, speaks with Alice Chen, MD, about the impact of misinformation and disinformation during elections, the health care issues on the 2024 ballot and more. Content warning: This episode discusses sensitive topics surrounding women’s health and reproductive rights. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Chen 0:32 • The interview 1:38 • How did you get into the public health and advocacy spaces? 1:58 • Have you seen an evolution in medical professionals becoming more involved in politics and advocacy? 5:08 • How has misinformation impacted politics, health care, policy and the election? 7:25 • As health care workers, how do we address misinformation to help our communities and patients? 10:51 • Do you feel that health care workers should use social media for this type of advocacy work? 15:26 • Is there more of a need for health care workers to be doing this work now than it was pre-social media? 18:14 • Jain and Chen on how discussions around politics have changed in the last decade. 26:05 • What are the major health care topics being discussed and impacted by this upcoming election? Why is health on the ballot? 28:33 • Jain and Chen on women’s health and why it matters in this election. 30:58 • What are health care workers doing to promote advocacy? 37:05 • If you could summarize this episode in one minute, what would you want listeners to take away? 45:36 • How to contact Chen 46:11 • Thanks for listening 46:53 Alice T. Chen, MD, is a mom, physician and national leader in public health, physician advocacy and community organizing. She serves as the co-chair of the board of directors of Health Care Without Harm. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Chen can be reached @atychen on X and on LinkedIn . Disclosures: Jain and Chen report no relevant financial disclosures.…

Oncology Overdrive

1
Advocating for Patient Access with Amita Patnaik, MD, FRCPC 35:47

22 weeks ago35:47

35:47

In this episode, host Shikha Jain, MD, speaks with Amita Patnaik, MD, FRCPC, about providing patient access to breakthrough drug developments, bringing early phase cancer trials to physicians and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Patnaik 0:21 • The interview 1:23 • How did you decide to become an oncologist, and how did you end up co-founding the START Center for Cancer Research ? 1:32 • Can you tell me about START’s overarching purpose and where you see its need being most fulfilled? […] What do you hope START will accomplish in the next five to ten years? 11:33 • How successful has START been at including underrepresented patient populations in clinical data? 17:52 • What are some challenges you’ve found as you have navigated through founding a company and executing its mission? 21:48 • What is next for you? 25:21 • If someone else wanted to create a company like START, what are some tips you would give them? 27:23 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 32:03 • How to contact Patnaik 34:44 • Thanks for listening 35:27 Amita Patnaik, MD, FRCPC, is an internationally recognized medical oncologist and the co-founder of the START Center for Cancer Research. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Patnaik can be reached via email amita.patnaik@startresearch.com or via the START website .…

Oncology Overdrive

1
Developing Products for Cancer Care with Annmarie Ison 31:23

24 weeks ago31:23

31:23

In this episode, host Shikha Jain, MD, speaks with Annmarie Ison about developing safe and accurate software, how software can improve health care disparities and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Ison 0:25 • The interview 1:10 • Tell me about how you got into this space […] Can you explain what software development is? 1:34 • What is Elekta and what does the company do? 10:24 • How do you feel that this type of innovation is transforming cancer care and treating oncology patients? 13:19 • How is Elekta and its services helping to address health care disparities? 19:32 • Where do you think AI fits into the bigger picture of the cancer care landscape? 24:53 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 28:29 • How to contact Ison 30:25 • Thanks for listening 31:05 Annmarie Ison is head of customer service for the software business line at Elekta. She has over 25 years of experience as a software development professional, specializing in product development and software architecture for information management systems and radiation therapy delivery devices. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Ison can be reached via email annmarie.ison@elekta.com or via LinkedIn . Disclosures: Jain and Ison report no relevant financial disclosures.…

Oncology Overdrive

1
Entrepreneurship in Biotech with Brian Fiske 33:23

26 weeks ago33:23

33:23

In this episode, host Shikha Jain, MD, speaks with Brian Fiske about bringing biotech business ideas to fruition, antibody drug conjugate developments and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Fiske 0:21 • The interview 1:45 • How did you get to where you are today, and how did you become interested in this specific area of health care? 2:06 • What is a timeline from start to finish to bringing an innovative idea to fruition? 6:01 • How long does it take to form an actual company from an idea? 11:20 • How do you figure out who you need on your team to move an idea forward? 15:11 • Tell us about your previous positions at biotech companies, and how did they help lead you into your current space? 20:22 • What excites you about your job? […] Why do you feel the drive and desire to do this type of work? 24:40 • Where do you see the work at Mythic Therapeutics doing in the next five to ten years for patient care? 26:27 • How can we work towards making sure this type of innovative work is available and accessible to patients? 29:20 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 31:16 • How to contact Fiske 32:12 • Thanks for listening 32:56 Brian Fiske is chief scientific officer and co-founder of Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate therapies for the treatment of a wide range of cancers. We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Fiske can be reached via LinkedIn or the Mythic Therapeutics website . Disclosures: Jain and Fiske report no relevant financial disclosures.…

Oncology Overdrive

1
Women in medicine roundtable, Part 2: On empowerment and advocacy 25:19

28 weeks ago25:19

25:19

On this special edition episode, Shikha Jain, MD, with Physicianary’s Hansa Bhargava, MD, and Mend the Gap’s Dagny Zhu, MD, discuss the evolution of empowering yourself and others and advocacy with a panel of guests. • Intro 1:01 • What does it mean to empower women in medicine, and what are the ways that we can really empower others to achieve the things that they may not see for themselves? 2:39 • What are some ways in which you have empowered or hope to empower women in medicine? Are there tips or skills that have worked well? 5:43 • How have you been empowered by others, or have helped others find their voices? 8:38 • Do you agree that the conversation is changing toward a cultural shift in empowerment for women in health care? 13:53 • What are some challenges facing advocacy and empowerment? What do you do when your advocacy work is not being received or it is a struggle to speak up for someone? 18:40 • Emphasizing the importance of communication in advocacy work. 24:00 • Intro to Physicianary’s part 3 on physician burnout and work-life balance. 24:16 • Thanks for listening 25:00 Vineet Arora, MD, MAPP (NAM), is a Herbert T. Abelson professor of medicine, vice dean of education in the biological sciences division and dean for medical education at the University of Chicago Pritzker School of Medicine. She is also an elected member of the National Academy of Medicine. She is a founding member of the 501c3 Women of Impact and advisor to the Women in Medicine Summit. Jennifer Bepple, MD, MMCi, is a double board-certified physician in urology and informatics. She is a member of the American Telemedicine Association, American Urologic Association and American Medical Informatics Association and holds a certification from the American Board of Telehealth and the American Board of AI in Medicine. Hansa Bhargava, MD, is Healio's chief clinical strategy and innovation officer. Listen to her Healio podcast, Physicianary . Shikha Jain, MD, FACP, is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the division of hematology and oncology, the director of communication strategies in medicine and the associate director of oncology communication & digital innovation at the University of Illinois Cancer Center in Chicago. Mara Schenker, MD, FACS, FAOA, is an orthopedic trauma surgeon at Grady Memorial Hospital. She is double board certified in orthopedic surgery and clinical informatics. She serves as the chief of orthopedics and associate chief medical information officer. She is an associate professor of orthopedics at Emory University School of Medicine. She serves on multiple boards for medical and digital technology advisory and sits on major national committees for the American Academy of Orthopaedic Surgeons, AAMC, American College of Surgeons and the Orthopaedic Trauma Association. Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on X @DZEyeMD . We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com . Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/ . Follow Dr. Jain on X: @ShikhaJainMD . Disclosures: The hosts and guest report no relevant financial disclosures.…

Oncology Overdrive

1
Celebrating 100 episodes with the original Dr. Jain, my dad! 51:08

30 weeks ago51:08